Fulminant hepatic failure
Fulminant hepatic failure (FHF) refers to a syndrome in which patients without liver disease suddenly develop massive hepatocellular necrosis or significant liver function abnormalities, and hepatic encephalopathy (HE) occurs within 8 weeks after the onset of the first symptoms.
-
Site of disease:
liver -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Intestinal paralysis Progressive liver shrinkage Continuous fever Flagging nose Disappearance of bowel sounds -
Concurrent disease:
Related Drugs
Hepatocyte Growth Factor for Injection
Indication: Used as an auxiliary treatment for various severe viral hepatitis (acute, subacute, early or middle stages of chronic severe hepatitis).
Hepatocyte Growth Factor for Injection
Indication: Used as an auxiliary treatment for various severe viral hepatitis (acute, subacute, early or middle stages of chronic severe hepatitis).